|
|
|
|
ADHD Medical and Health News Headlines
|
|
|
|
|
|
|
All Recent ADHD Medical Condition News Headlines |
|
|
|
|
Pump Your Brain--And Other Stories from MIND
Cognitive-enhancement drugs have been in the headlines a great deal lately--they stoke your gray matter, enabling greater focus and attention for longer periods of time, users say. But their long-term effects are uncertain and unknown, on both brain and body. In the meantime, there’s something you can do that helps both areas but that doesn’t have any known mental health risks. As study after study has shown, simple physical activity not only builds your physique and cardiovascular health: it also helps to sharpen the wetware in your skull and thwarts mental decline as you advance in years. Check out our feature story, “Fit Body, Fit Mind?” by psychologist Christopher Hertzog and his colleagues. You’ll be glad you did.A different kind of brain performance ques......
POSTED 07/01/2009 at 09:00 AM --
|
VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD
(Porter Novelli) Shire announced results from a Phase 3b study that found VYVANSE (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment in adults with Attention Deficit Hyperactivity Disorder. VYVANSE is the first approved stimulant for adults with ADHD to be evaluated in this setting, and these data were presented at the New Clinical Drug Evaluation Unit meeting. VYVANSE is approved by the FDA for ADHD in children aged 6 to 12 years and adults with ADHD. (Source: EurekAlert! - Social and Behavioral Science)...
POSTED 06/30/2009 at 11:00 PM --
|
Potential Utility of Screening Selected Injured Children for ADHD
(Source: AAP Grand Rounds)...
POSTED 06/30/2009 at 06:00 PM --
|
Pregnancy complications may increase autism risk
Age of parents also likely to be a risk-factor, study findsRelated items from OnMedicaDepression in dads harms childrenChildhood abuse associated with psychosis in womenHead injury ADHD link madeOver 50% of premature pupils struggle in schoolAutism consultation is launched by government (Source: OnMedica Latest News)...
POSTED 06/30/2009 at 06:00 PM --
|
[Articles] Institutional Rearing and Psychiatric Disorders in Romanian Preschool Children
CONCLUSIONS: Institutional rearing was associated with substantial psychiatric morbidity. Removing young children from institutions and placing them in families significantly reduced internalizing disorders, although girls were significantly more responsive to this intervention than boys. (Source: Am J Psychiatry)...
POSTED 06/30/2009 at 06:00 PM --
|
Placebo Effects In Caregivers May Change Behavior Of Children With ADHD
Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder and improve their behavior. Now a recent review of research by pediatric psychologists suggests that such medication, or the assumption of medication, may produce a placebo effect -- not in the children, but in their teachers, parents or other adults who evaluate them. (Source: ScienceDaily Headlines)...
POSTED 06/30/2009 at 04:00 AM --
|
ADHD drug in kid, placebo effect in adults
BUFFALO, N.Y., June 30 (UPI) -- U.S. researchers find a placebo effect, not in children taking the medication for attention deficit-hyperactive disorder, but in the adults in their lives. (Source: Health News - UPI.com)...
POSTED 06/29/2009 at 11:57 PM --
|
[Articles] Beyond ADHD and narcolepsy: psychostimulants in general psychiatry
This article reviews the recent literature regarding psychostimulant use in general and consultation-liaison psychiatry. Although psychostimulants continue to attract clinical research, there is currently not enough evidence to recommend their routine use for general psychiatric conditions. (Source: Advances in Psychiatric Treatment)...
POSTED 06/29/2009 at 06:00 PM --
|
Current issues around the pharmacotherapy of ADHD in children and adults
Conclusion Although pharmacotherapy is increasing common in the treatment of ADHD in both children and adults, there are still a lot
of questions about side effects and how best to counter them. This suggests an important role for close monitoring of children
and adults treated with stimulants or atomoxetine.
Content Type Journal ArticleCategory CommentaryDOI 10.1007/s11096-009-9302-3Authors
Willemijn M. Meijer, PHARMO Institute P.O. Box 85222 3508 Utrecht The NetherlandsAdrianne Faber, SIR Institute for Pharmacy Practice and Policy Leiden The NetherlandsEls van den Ban, Altrecht, Division Child, Youth and Family Utrecht The NetherlandsHilde Tobi, Wageningen University and Research Centre Research Methodology Wageningen The Netherlands
Journal Pharmacy World & ScienceOnline I......
POSTED 06/29/2009 at 03:23 AM --
|
Placebo effects in caregivers may change behavior of children with ADHD
(University at Buffalo) Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder and improve their behavior. Now a recent review of research by University at Buffalo pediatric psychologists suggests that such medication, or the assumption of medication, may produce a placebo effect -- not in the children, but in their teachers, parents or other adults who evaluate them. (Source: EurekAlert! - Social and Behavioral Science)...
POSTED 06/28/2009 at 11:00 PM --
|
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
CONCLUSIONS: We found evidence that stimulant treatment decreases the risk for subsequent comorbid psychiatric disorders and academic failure in youth with ADHD. (Source: PEDIATRICS)...
POSTED 06/28/2009 at 06:00 PM --
|
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
CONCLUSION: Exposure to methylphenidate and amphetamines salts showed similar risk for cardiac ED visits. Additional population-based studies that address manifestation of serious heart disease, especially after long-term use, dosage comparisons, and interactions with preexisting cardiac risk factors are needed to inform psychiatric treatment decisions. (Source: PEDIATRICS)...
POSTED 06/28/2009 at 06:00 PM --
|
Functioning at School Age of Moderately Preterm Children Born at 32 to 36 Weeks' Gestational Age
CONCLUSIONS: Cognitive and emotional regulation difficulties affect functioning of moderately preterm children, as school problems, a slightly lower IQ, attention and behavioral problems are found when they are compared with term-born children. Identification and monitoring of precursors of these problems at younger age is needed in view of prevention purposes. (Source: PEDIATRICS)...
POSTED 06/28/2009 at 06:00 PM --
|
The Future of Pediatrics: Mental Health Competencies for Pediatric Primary Care
In this report, the American Academy of Pediatrics proposes competencies requisite for providing mental health and substance abuse services in pediatric primary care settings and recommends steps toward achieving them. Achievement of the competencies proposed in this statement is a goal, not a current expectation. It will require innovations in residency training and continuing medical education, as well as a commitment by the individual clinician to pursue, over time, educational strategies suited to his or her learning style and skill level. System enhancements, such as collaborative relationships with mental health specialists and changes in the financing of mental health care, must precede enhancements in clinical practice. For this reason, the proposed competencies begin with knowledg......
POSTED 06/28/2009 at 06:00 PM --
|
[Articles] Children's Beliefs About Causes of Childhood Depression and ADHD: A Study of Stigmatization
CONCLUSIONS: This study demonstrated a consistent presence of stigmatization in children's beliefs about the causes of childhood mental health problems. Low effort, parenting, and substance abuse together tapped a moralistic and blaming view of mental health problems. The results reinforce the need to address stigmatization of mental disorders and the relative stigmatization of different causal beliefs. The findings of variation by ethnicity and diagnosis can inform and target antistigmatization efforts. (Source: Psychiatr Serv)...
POSTED 06/28/2009 at 06:00 PM --
|
Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
Authors: Garnock-Jones KP, Keating GM
Atomoxetine (Strattera(R)) is a selective norepinephrine (noradrenaline) reuptake inhibitor that is not classified as a stimulant, and is indicated for use in patients with attention-deficit hyperactivity disorder (ADHD). Atomoxetine is effective and generally well tolerated. It is significantly more effective than placebo and standard current therapy and does not differ significantly from or is noninferior to immediate-release methylphenidate; however, it is significantly less effective than the extended-release methylphenidate formulation OROS(R) methylphenidate (hereafter referred to as osmotically released methylphenidate) and extended-release mixed amfetamine salts. Atomoxetine can be administered either as a single daily dose or split into tw......
POSTED 06/27/2009 at 03:47 PM --
|
Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.
Authors: Charach G, Kaysar N, Grosskopf I, Rabinovich A, Weintraub M
Many psychotropic drugs may affect plasma lipids profile and their metabolism, with carbamazepine being the best known among them. Methylphenidate is a piperidine derivative structurally related to amphetamines and acts as a central nervous system stimulant. Its effect on lipid metabolism has not been investigated. The authors evaluated how methylphenidate affects the lipid profile in the plasma of patients diagnosed as having attention-deficit hyperactivity disorder (ADHD). All consecutive patients undergoing treatment for ADHD at the Adolescent Psychiatric Clinic (2003-2007) were enrolled. Blood samples for total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ......
POSTED 06/27/2009 at 11:07 AM --
|
Working memory in children with developmental disorders.
Authors: Alloway TP, Rajendran G, Archibald LM
The aim of the present study was to directly compare working memory skills across students with different developmental disorders to investigate whether the uniqueness of their diagnosis would impact memory skills. The authors report findings confirming differential memory profiles on the basis of the following developmental disorders: Specific Language Impairment, Developmental Coordination Disorder (DCD), Attention-Deficit/Hyperactivity Disorder, and Asperger syndrome (AS). Specifically, language impairments were associated with selective deficits in verbal short-term and working memory, whereas motor impairments (DCD) were associated with selective deficits in visuospatial short-term and working memory. Children with attention problems ......
POSTED 06/27/2009 at 07:37 AM --
|
The Unity and Diversity of Inattention and Hyperactivity/Impulsivity in ADHD: Evidence for a General Factor with Separable Dimensions.
Authors: Toplak ME, Pitch A, Flora DB, Iwenofu L, Ghelani K, Jain U, Tannock R
To examine the unity and diversity of inattention and hyperactivity/impulsivity symptom domains of Attention-Deficit/Hyperactivity Disorder (ADHD) in a clinical sample of adolescents with ADHD. Parents and adolescents were administered a semi-structured diagnostic interview, the Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL), to assess adolescent ADHD. Data from 201 parent interviews and 189 adolescent interviews were examined. Four potential factor structures for the 18 ADHD symptoms were tested using confirmatory factor analysis: two models with correlated factors and two bifactor models. A bifactor model with two specific factors best ......
POSTED 06/26/2009 at 06:00 PM --
|
Adolescent With History of Hypercholesterolemia and ADHD: Evidence-based Practice
Beverly Giordano, MS, RN, CPNP (Source: Journal of Pediatric Health Care)...
POSTED 06/26/2009 at 09:45 AM --
|
|
|
|
|
|
 |
|
|
|
|
|
IMPORTANT NOTICE:
The information provided on this site is intended for your general knowledge only and is not a substitute for professional
medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a
qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
|
|
|
|
|
|
|
|
